文献速递生殖医学

冻存卵巢组织的体外成熟与移植:理解卵巢长寿

In-vitro maturation and transplantation of cryopreserved ovary tissue: understanding ovarian longevity.
PubMed 文献 · Reprod Biomed Online · 2021-12-08

该研究基于24年冻存卵巢组织移植经验,对119例2至35岁女性行卵巢冻存,其中最后13例同时行卵母细胞体外成熟(IVM);17例 later 解冻移植,全部在移植后5个月恢复卵巢功能,13例(76%)经性交妊娠,获19例健康活产,其中3例白血病患者获6例活产;35%的生发泡卵母细胞经简单培养基发育为成熟中期II卵母细胞。

要点

  • 卵巢组织冻存是保存生育力的稳健方法,白血病患者亦适用,无需延迟癌症治疗。
  • 简单培养基常可获得多个成熟卵母细胞,无需卵巢刺激。
  • 卵巢刺激仅用于从卵巢取出卵母细胞,亦可在冻存时简单解剖完成。

核心结论

  • 卵巢组织冻存是保存生育力的稳健方法,白血病患者亦适用,无需延迟癌症治疗。
  • 简单培养基常可获得多个成熟卵母细胞,无需卵巢刺激。
  • 卵巢刺激仅用于从卵巢取出卵母细胞,亦可在冻存时简单解剖完成。
  • 压力和仅八个「核心基因」控制原始卵泡募集与发育。

研究设计与样本

  • 24年间共119例2至35岁女性行卵巢冻存,最后13例同时行卵母细胞体外成熟(IVM)。
  • 17例 later 解冻并移植回卵巢组织。

主要发现

  • 每例女性移植后5个月均恢复卵巢功能。
  • 移植后4个月抗苗勒管激素(AMH)浓度升高而FSH下降。
  • 移植物持续工作长达8年。
  • 17例中13例(76%)经性交至少妊娠一次,获19例健康活产,包括3例白血病患者的6例活产。
  • 35%的生发泡卵母细胞经简单培养基发育为成熟中期II卵母细胞。

临床怎么用

  • 作者认为卵巢组织冻存是保存生育力的稳健方法,白血病患者亦适用,无需延迟癌症治疗。
  • 作者认为简单培养基常可获得多个成熟卵母细胞,无需卵巢刺激。
  • 作者认为卵巢刺激仅用于从卵巢取出卵母细胞,亦可在冻存时简单解剖完成。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Is it possible to use experience gained from 24 years of frozen ovarian transplantation, and from recent experience with in-vitro gametogenesis to accomplish simple and robust in-vitro maturation (IVM) of oocytes from human ovarian tissue? DESIGN: A total of 119 female patients between age 2 and 35 years old underwent ovary cryopreservation (as well as in-vitro maturation of oocytes and IVM in the last 13 individuals) over a 24-year period. Up to 22 years later, 17 returned to have their ovary tissue thawed and transplanted back. RESULTS: Every woman had a return of ovarian function 5 months after transplant, similar to previous observations. As observed before, anti-Müllerian hormone (AMH) concentration rose as FSH fell 4 months later. The grafts continued to work up to 8 years. Of the 17, 13 (76%) became pregnant with intercourse at least once, resulting in 19 healthy live births, including six live births from three women who had had leukaemia. Of the harvested germinal vesicle oocytes, 35% developed with simple culture media into mature metaphase II oocytes. CONCLUSIONS: The authors concluded the following. First, ovary tissue cryopreservation is a robust method for preserving fertility even for women with leukaemia, without a need to delay cancer treatment. Second, many mature oocytes can often be obtained from ovary tissue with simple media and no need for ovarian stimulation. Third, ovarian stimulation only be necessary for removing the oocyte from the ovary, which can also be accomplished by simple dissection at the time of ovary freezing. Finally, pressure and just eight 'core genes' control primordial follicle recruitment and development.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Silber SJ, Goldsmith S, Castleman L, et al. In-vitro maturation and transplantation of cryopreserved ovary tissue: understanding ovarian longevity. Reprod Biomed Online. 2021. PMID: 35151573. doi:10.1016/j.rbmo.2021.11.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。